Lucid Diagnostics Inc. — Investor Relations & Filings
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics company focused on the prevention of esophageal cancer. The company's primary product is the EsoGuard Esophageal DNA Test, a non-invasive diagnostic tool designed for the early detection of esophageal precancer, including Barrett's esophagus. Utilizing targeted next-generation sequencing (NGS) technology, EsoGuard analyzes DNA biomarkers from cells collected in a simple, office-based procedure. This allows for the screening of at-risk patients, such as those with chronic gastroesophageal reflux disease (GERD), without the need for an initial endoscopy. The company aims to improve patient outcomes by identifying precancerous conditions at a treatable stage, thereby preventing the progression to esophageal adenocarcinoma.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2022 | 2022-07-13 | English | |
| Regulatory Filings 2022 | 2022-06-23 | English | |
| Regulatory Filings 2022 | 2022-06-22 | English | |
| Regulatory Filings 2022 | 2022-06-16 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-09 | English | |
| INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-08 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 13226488 | Regulatory Filings 2022 | 2022-07-13 | English | ||
| 13226489 | Regulatory Filings 2022 | 2022-06-23 | English | ||
| 13226490 | Regulatory Filings 2022 | 2022-06-22 | English | ||
| 13226491 | Regulatory Filings 2022 | 2022-06-16 | English | ||
| 13226492 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-09 | English | ||
| 13226493 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-08 | English | ||
| 13226495 | Interim / Quarterly Report 2022 | 2022-05-16 | English | ||
| 13226498 | Regulatory Filings 2022 | 2022-05-12 | English | ||
| 13226496 | Regulatory Filings 2022 | 2022-05-09 | English | ||
| 13226497 | Regulatory Filings 2022 | 2022-05-02 | English | ||
| 13226499 | Proxy Solicitation & Information Statement 2022 | 2022-05-02 | English | ||
| 13226500 | Regulatory Filings 2022 | 2022-04-22 | English | ||
| 13226502 | Annual Report 2021 | 2022-04-05 | English | ||
| 13226503 | Regulatory Filings 2022 | 2022-04-04 | English | ||
| 13226504 | Regulatory Filings 2022 | 2022-04-01 | English | ||
Market data
Market data not available
Price history
Peer group · Other human health activities n.e.c
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
3billion Inc.
Uses an AI platform for rare disease diagnosis and continuo…
|
394800 | KR | Human health and social work ac… |
|
AdaptHealth Corp.
Provider of home medical equipment, supplies, and related h…
|
AHCO | US | Human health and social work ac… |
|
Addus HomeCare Corp
Provider of in-home personal care, home health, and hospice…
|
ADUS | US | Human health and social work ac… |
|
ADICON Holdings Limited
Provider of independent clinical laboratory services for ho…
|
9860 | KY | Human health and social work ac… |
|
ADVENTA BHD
Healthcare group manufacturing medical products, providing …
|
— | MY | Human health and social work ac… |
|
Aidigong Maternal & Child Health Limited
Provides comprehensive maternal and child healthcare, postp…
|
286 | HK | Human health and social work ac… |
|
Aimei Health Technology Co., Ltd.
A special purpose acquisition company (SPAC) focused on the…
|
AFJK | US | Human health and social work ac… |
|
Allcore
Holding company providing consulting services for small and…
|
CORE | IT | Human health and social work ac… |
|
ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A.
Provides diagnostic imaging, clinical analysis, and digital…
|
— | BR | Human health and social work ac… |
|
ALLURION TECHNOLOGIES, INC.
Offers a weight-loss platform featuring a procedure-less, s…
|
ALUR | US | Human health and social work ac… |
Lucid Diagnostics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33983/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33983 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33983 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33983 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33983}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lucid Diagnostics Inc. (id: 33983)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.